Inkef

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Silverflow is a payment processing technology company based in Amsterdam, Netherlands, founded in 2019. The company offers a cloud-based payments platform that enables payment service providers (PSPs) to gain direct access to card networks. This innovative platform allows PSPs to enhance their services by instantly adding new functionalities and obtaining real-time insights into transaction fees. Additionally, Silverflow provides smart data directly from the networks, which helps payment providers serve their merchants more effectively. By streamlining data flow and utilizing basic application programming interfaces, Silverflow aims to improve agility, transparency, and security in global payment operations, benefiting not only PSPs but also merchants and acquirers.

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.

Silverflow is a payment processing technology company based in Amsterdam, Netherlands, founded in 2019. The company offers a cloud-based payments platform that enables payment service providers (PSPs) to gain direct access to card networks. This innovative platform allows PSPs to enhance their services by instantly adding new functionalities and obtaining real-time insights into transaction fees. Additionally, Silverflow provides smart data directly from the networks, which helps payment providers serve their merchants more effectively. By streamlining data flow and utilizing basic application programming interfaces, Silverflow aims to improve agility, transparency, and security in global payment operations, benefiting not only PSPs but also merchants and acquirers.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Silverflow is a payment processing technology company based in Amsterdam, Netherlands, founded in 2019. The company offers a cloud-based payments platform that enables payment service providers (PSPs) to gain direct access to card networks. This innovative platform allows PSPs to enhance their services by instantly adding new functionalities and obtaining real-time insights into transaction fees. Additionally, Silverflow provides smart data directly from the networks, which helps payment providers serve their merchants more effectively. By streamlining data flow and utilizing basic application programming interfaces, Silverflow aims to improve agility, transparency, and security in global payment operations, benefiting not only PSPs but also merchants and acquirers.

Salvia BioElectronics B.V., founded in 2017 and headquartered in Eindhoven, the Netherlands, focuses on developing bioelectronic therapies for individuals with chronic neurological conditions, particularly chronic migraines. Drawing its name from the Latin word for "to stay healthy," Salvia is committed to providing drug-free, effective, and side-effect-free solutions. The company leverages a team of experienced professionals, including entrepreneurs, engineers, and scientists, who have extensive backgrounds in the medical device industry. Salvia aims to make its innovative bioelectronic solutions widely accessible, addressing the needs of patients seeking alternative treatments for their conditions.

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.

Cashforce BV operates a sophisticated cash flow management and forecasting platform designed to enhance financial efficiency for businesses. Founded in 2013 and based in Antwerp, Belgium, with additional offices in New York, Amsterdam, Copenhagen, and London, the company serves various sectors, including wholesale and distribution, transportation, logistics, and manufacturing. Its platform offers users the ability to forecast cash flows across multiple companies, bank accounts, and currencies, allowing for early detection of potential cash shortages or surpluses. Cashforce distinguishes itself through seamless integration with various ERP and banking systems, enabling detailed transaction-level analysis. The platform also features an AI-based simulation engine that supports multiple cash flow scenarios and impact assessments, providing cash visibility to multinational corporations in over 120 countries. The company has formed a strategic alliance with Treasury Intelligence Solutions GmbH to further enhance its offerings.

Blendle is a digital media platform that allows readers to purchase articles from various Dutch and Belgian newspapers and magazines, including prominent publications like the Economist. Users can buy individual articles for prices ranging from €0.10 to €0.30, and they are presented with a selection of recommendations similar to social media feeds. New users are provided with an initial credit of €2.50 to explore the platform. The service includes a brief refund window for article purchases, after which Blendle retains a 30% commission on sales. By offering a pay-per-article model, Blendle aims to enhance access to quality journalism and cater to readers' preferences through personalized recommendations.

Bloomon B.V., founded in 2014 and headquartered in Amsterdam, Netherlands, operates an online retail platform specializing in flower delivery across Europe. The company emphasizes a direct-to-consumer model, sourcing flowers directly from growers to ensure quality. Bloomon offers a subscription service allowing customers to conveniently arrange their orders online, with the flexibility to pause, change, or cancel deliveries without any commitment. This approach enables users to create customized packaging with fresh flowers, enhancing their overall experience. Focused on client satisfaction and product quality, Bloomon prioritizes service over competition in the online flower market.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.

InteRNA Technologies B.V. is a biotechnology company focused on the development of microRNA (miRNA)-based therapeutics for cancer treatment. The company's innovative approach leverages the unique properties of miRNAs to target previously undruggable pathways involved in cancer initiation, progression, and metastasis. By utilizing advanced techniques such as massively parallel sequencing and proprietary bioinformatics, InteRNA analyzes and validates miRNA sequences to enhance drug efficacy and reduce resistance to existing therapies. Founded in 2006, the company operates from Nijmegen, the Netherlands, and has a dedicated research and development center in Utrecht. Recently, InteRNA has secured additional equity financing to advance its lead program for melanoma treatment, demonstrating its commitment to developing novel solutions in oncology.

Audion Therapeutics BV is a biopharmaceutical company based in Amsterdam, Netherlands, focused on the discovery, development, and commercialization of therapies for ear-related diseases, particularly hearing loss. Founded in 2008, the company is engaged in small molecule drug discovery aimed at regenerating inner hair cells, which are vital for hearing. Audion Therapeutics leverages a unique approach by targeting a protein complex known as gamma-secretase to address sensorineural hearing loss, often associated with aging. The company's intellectual property portfolio comprises new drug molecules, advanced delivery systems, and innovative tools for research in hearing and hearing loss.

Bloomon B.V., founded in 2014 and headquartered in Amsterdam, Netherlands, operates an online retail platform specializing in flower delivery across Europe. The company emphasizes a direct-to-consumer model, sourcing flowers directly from growers to ensure quality. Bloomon offers a subscription service allowing customers to conveniently arrange their orders online, with the flexibility to pause, change, or cancel deliveries without any commitment. This approach enables users to create customized packaging with fresh flowers, enhancing their overall experience. Focused on client satisfaction and product quality, Bloomon prioritizes service over competition in the online flower market.

ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.

Sapiens Steering Brain Stimulation GmbH is an emerging medical device company whose mission is to deliver superior solutions for deep brain stimulation (DBS) therapy. Sapiens' ambition is to provide a unique, high-resolution, and MRI- compatible DBS system that will improve patient comfort and therapeutic outcome, initially for patients with Parkinson's disease. Sapiens, with offices in Eindhoven, the Netherlands and Munich, Germany, is founded in 2011 as a spin-out of Royal Philips Electronics. Its steering brain stimulation (SBS) system and image-guided programming are based upon patented technologies.

Lanthio Pharma B.V. is a biopharmaceutical company based in Groningen, the Netherlands, specializing in the discovery and development of lantipeptide drugs aimed at treating conditions such as fibrosis, stroke, heart failure, and multiple sclerosis. The company employs its proprietary lanthionine-peptide drug discovery technology, LanthioPep™, to create novel peptide therapeutics that exhibit enhanced resistance to peptidase degradation and high receptor specificity. Among its product pipeline are LP2, designed to target fibrosis; PanCyte, intended for ischemic stroke recovery and related conditions; a Lanthi-apelin agonist for various organ systems; and Lanthi-galanin for multiple sclerosis. Founded in 2010, Lanthio Pharma operates as a subsidiary of Morphosys AG, focusing on generating stable, peptidase-resistant peptides that possess high intrinsic activity for several G-protein-coupled receptor targets.

Robin Radar Systems B.V., based in The Hague, the Netherlands, specializes in developing radar systems for bird detection and tracking. The company offers several products, including a 2D Mobile system that detects bird presence, number, location, direction, speed, and route over distances of up to 20 kilometers; a 3D Fixed system that provides similar data up to 10 kilometers; and a 3D Flex system that combines horizontal S-band radar with flexible frequency modulated continuous wave radar. Their Military XL system is designed to assist air forces in preventing bird strikes. Robin Radar Systems also offers essential support services such as testing, training, documentation, and maintenance. Established in 2010 as a spin-off from the Dutch Research Institute for Applied Science (TNO), the company has access to advanced radar technology developed for bird tracking since the 1970s. Their innovative solutions aim to enhance safety and sustainability for wind farms, airports, and other operations while minimizing environmental impacts.